title: Type 2 diabetes and cancer: should we prefer antihyperglycaemic treatments without unnecessarily increasing insulin levels?
authors.affiliation: Diabetology, Endocrinology and Metabolism, Diabetes-Center, Quakenbrück, Germany S.Matthaei@ckq-gmbh.de.
authors.forename: Stephan
authors.initials: S
authors.lastname: Matthaei
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D006946:Hyperinsulinism / Q000139:chemically induced* / Q000150:complications; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D007328:Insulin / Q000009:adverse effects*; D009369:Neoplasms / Q000209:etiology*
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin